The bruton's tyrosine kinase inhibitor evobrutinib ameliorates meningeal inflammation in experimental autoimmune encephalomyelitis

Kim, S; Boschert, U; Grenningloh, R; Bhargava, P

MULTIPLE SCLEROSIS JOURNAL, 2020; 26 (3_SUPPL): 313